Prices of crucial drugs likely to fall steeply
“We plan to cap traders’ margin at around 100% across drug categories — generic, branded, scheduled and non-scheduled,” minister of state for chemicals and fertilisers Hansraj Gangaram Ahir told HT on Tuesday.
Drug prices may see a sharp drop with the government planning to prune the profit margins of chemists and wholesalers, a move that will especially prove to be beneficial to those battling cancer, heart, kidney and liver illnesses.
The retail price of some of the drugs is 11 times (1000%) higher than their production cost, but the government wants to lower drug prices.
“We plan to cap traders’ margin at around 100% across drug categories — generic, branded, scheduled and non-scheduled,” minister of state for chemicals and fertilisers Hansraj Gangaram Ahir told HT on Tuesday.
“Chemists and distributors are currently charging exorbitant margins which are as high as 1000% and above… Controlling and squeezing the margins would bring down the prices…” A notification could be sent out in the next six months, he said.
Pharma firms do not offer big margins on over- the-counter drugs such as Crocin and Disprin due to competition. But, drugs for cancer, heart conditions, HIV, and liver diseases are sold at huge margins.
There is a wide difference in the landing cost — the price at which a drug is offered to a seller — and the maximum retail price (MRP) – landing cost plus the margin — of drugs for these illnesses, the government has found.
Stay informed on Business News, TCS Q4 Results Live along with Gold Rates Today, India News and other related updates on Hindustan Times Website and APPs